SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

Director Dealing

11 Oct 2016 09:55

RNS Number : 2225M
Nostra Terra Oil & Gas Company PLC
11 October 2016
 

 

 

 

 

 

11 October 2016

Nostra Terra Oil and Gas Company plc

("Nostra Terra" or the "Company")

 

Director Dealing

 

Nostra Terra (AIM:NTOG) is pleased to announce that it has agreed today to issue 859,817 ordinary shares of 0.1 pence ("Fee Shares") to its Chairman, Ewen Ainsworth, in lieu of director fees for the period from 1 July 2015 to 30 September 2016.

When Ewen Ainsworth joined Nostra Terra as Chairman of the Company on 24 June 2015 he agreed to receive 40 per cent of his annual fee in share based payments. This reflected his belief in Nostra Terra's vision and also his recognition of the need for prudence in cash remuneration for directors in order to deliver on the Company's strategy.

One third of the Fee Shares will be issued directly to Mr Ainsworth with the remainder to Discovery Energy Limited, a company controlled by him. The number of Fee Shares was calculated on the basis of the closing price for each calendar month during the 15-month period to September 2016. This results in an average issue price for the Fee Shares of 2.90 pence per share. Following the issue of the Fee Shares, Mr. Ainsworth will have an interest in 1,039,817 ordinary shares of 0.1 pence each equating to 1.09% of the enlarged issued ordinary share capital. In addition, as previously disclosed, Mr Ainsworth is interested in 1,000,000 warrants exercisable at 8.77 pence per share (as adjusted for the recent share consolidation).

In future the board of the Company intends to issue shares in lieu of fees to Mr Ainsworth on a quarterly basis in accordance with the same calculation as described above.

Application will be made to the London Stock Exchange for admission of the Fee Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 17 October 2016.

Following Admission, the Company will have 95,566,771 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 95,566,771. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, visit www.ntog.co.uk or contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

 

+1 480 993 8933

 

Strand Hanson Limited

(Nominated & Financial Adviser and Joint Broker)

 

+44 (0) 20 7409 3494

 

Rory Murphy / Ritchie Balmer

 

 

 

 

 

 

 

Vicarage Capital Limited (Joint Broker)

 

+44 (0) 20 3651 2910

 

Rupert Williams / Jeremy Woodgate

 

 

 

 

 

 

 

Cornhill Capital Ltd (Joint Broker)

 

+44 (0) 20 7710 9610

 

Nick Bealer / Colin Rowbury

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHVFLBFQBFZFBK
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.